A Longitudinal Study of Severe and Enduring Eating Disorders

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age14+
SponsorUppsala University Hospital

About this trial

The goal of this observational longitudinal study is to investigate characteristics and factors associated with the development of Severe and Enduring Eating Disorders (SEED). In this project, the researchers will follow two prospective cohorts of patients with eating disorders (ED), one adolescent (ages 14-17) and one adult (ages 18+), in terms of change in and impact of clinical, psychological, and biological risk factors.

Data will be collected at baseline, after treatment, two years after baseline, and thereafter five, 10 and 20 years after baseline. Participants will be asked to undergo a physical examination, leave blood samples, be interviewed, and fill in questionnaires. If the participants are minors, their care takers will also fill in the questionnaires.

The study aims to explore how clinical, psychological, and biological risk factors-including comorbidity, personality characteristics, difficulties with emotion regulation (ER), cognitive inflexibility, loneliness, severe ED symptoms, and inflammatory activation-contribute to a chronic course of the disorder.

Eligibility criteria

Qualifiers

found to meet the criteria for an eating disorder

being in need of treatment

having provided written informed consent (for minors, this includes consent from all caregivers and the minors themselves).

Disqualifiers

Eating disorders symptoms in need of emergency care

High risk for suicide

An inability to respond to the questionnaires due to e.g., lack of knowledge in Swedish.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

800 Participants
are grouped into 2 trial groups

Sponsors and collaborators

Uppsala University Hospital

Lead sponsor

Forte

Collaborator

The Söderström König Foundation

Collaborator

Fonden för psykisk hälsa

Collaborator